Abstract
Various interventions have been designed to improve HIV treatment adherence or reduce risk behaviors, but few have been designed to do both. One such intervention was recently tested in a randomized controlled trial conducted among 436 HIV-infected patients in Atlanta (mean age, 44; 71% men; 91% black). About 70% of participants were receiving potent antiretroviral therapy. The …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
